Poly-pharmacy Still Rules
Hope '4-A' Break in Asthma; FLAP Made Over New Bids
By Randy Osborne
Monday, March 29, 2010
Spring's onset brings pollen, allergies and - for many - asthma, which for as much as 35 percent of patients falls into the category of "uncontrolled." That's the high end of the estimated subset of about 22 million adult asthmatics in the U.S., and about the same number overseas. Corticosteroids aren't getting the job done, but which new target can, in a crowded market worth about $12.7 billion worldwide, according to GlobalData?
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.